Fig. 3From: Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case reportChanges of axial length in patient with bilateral posterior scleral reinforcement combined with orthokeratology and 0.01% atropine from 2015 to 2023 (application of orthokeratology and 0.01% atropine started from 2020 to 2023)Back to article page